- Home
- NL vs MRVI Comparison
NL vs MRVI Comparison
Compare NL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- MRVI
- Stock Information
- Founded
- NL 1891
- MRVI 2014
- Country
- NL United States
- MRVI United States
- Employees
- NL N/A
- MRVI N/A
- Industry
- NL Major Chemicals
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- MRVI Health Care
- Exchange
- NL Nasdaq
- MRVI Nasdaq
- Market Cap
- NL 316.5M
- MRVI 312.4M
- IPO Year
- NL N/A
- MRVI 2020
- Fundamental
- Price
- NL $6.64
- MRVI $2.71
- Analyst Decision
- NL Sell
- MRVI Hold
- Analyst Count
- NL 1
- MRVI 10
- Target Price
- NL $6.00
- MRVI $6.84
- AVG Volume (30 Days)
- NL 41.3K
- MRVI 1.9M
- Earning Date
- NL 08-06-2025
- MRVI 08-06-2025
- Dividend Yield
- NL 5.50%
- MRVI N/A
- EPS Growth
- NL 441.25
- MRVI N/A
- EPS
- NL 1.25
- MRVI N/A
- Revenue
- NL $148,242,000.00
- MRVI $241,856,000.00
- Revenue This Year
- NL $15.75
- MRVI N/A
- Revenue Next Year
- NL $2.44
- MRVI $10.91
- P/E Ratio
- NL $5.38
- MRVI N/A
- Revenue Growth
- NL N/A
- MRVI N/A
- 52 Week Low
- NL $5.21
- MRVI $1.67
- 52 Week High
- NL $9.42
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- NL 50.46
- MRVI 59.74
- Support Level
- NL $6.35
- MRVI $2.35
- Resistance Level
- NL $6.78
- MRVI $2.93
- Average True Range (ATR)
- NL 0.35
- MRVI 0.18
- MACD
- NL 0.05
- MRVI -0.01
- Stochastic Oscillator
- NL 64.29
- MRVI 62.39
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.